Early antibiotic use is associated with CMV risk and outcomes following allogeneic hematopoietic cell transplantation

Blood Adv. 2020 Dec 22;4(24):6364-6367. doi: 10.1182/bloodadvances.2020003277.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Cytomegalovirus
  • Cytomegalovirus Infections*
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Vancomycin

Substances

  • Anti-Bacterial Agents
  • Vancomycin